What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Radiation therapy
His primary areas of investigation include Radiation therapy, Internal medicine, Surgery, Oncology and Head and neck cancer.
His Radiation therapy research integrates issues from Cancer, Survival rate, Carcinoma, Hazard ratio and Concomitant.
His studies in Internal medicine integrate themes in fields like Endocrinology and Immediate early protein.
As a member of one scientific family, Jean Bourhis mostly works in the field of Surgery, focusing on Epidermoid carcinoma and, on occasion, Cetuximab.
His Oncology study deals with Fluorouracil intersecting with Docetaxel, Performance status and Taxane.
His Head and neck cancer research includes elements of Odds ratio, Combined Modality Therapy, Nuclear medicine and MEDLINE.
His most cited work include:
- Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. (2103 citations)
- Postoperative Irradiation With or Without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer (2062 citations)
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients (1916 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Radiation therapy, Oncology, Head and neck cancer and Surgery.
His Internal medicine study frequently links to adjacent areas such as Gastroenterology.
The Radiation therapy study which covers Cancer that intersects with Cancer research.
His biological study spans a wide range of topics, including Dose fractionation, Cetuximab and Fluorouracil.
Head and neck cancer connects with themes related to Meta-analysis in his study.
In most of his Surgery studies, his work intersects topics such as Epidermoid carcinoma.
He most often published in these fields:
- Internal medicine (44.99%)
- Radiation therapy (38.68%)
- Oncology (31.23%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (44.99%)
- Radiation therapy (38.68%)
- Oncology (31.23%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Radiation therapy, Oncology, Transplantation and Radiology.
His Radiation therapy research incorporates elements of Cancer and Immunotherapy.
He has included themes like Cancer research, Clinical trial and Immune system in his Cancer study.
His Oncology study combines topics from a wide range of disciplines, such as Chemotherapy, Myeloid, Randomized controlled trial, Retrospective cohort study and Stem cell.
His research in Transplantation intersects with topics in Gastroenterology and Incidence, Cumulative incidence.
The various areas that Jean Bourhis examines in his Head and neck cancer study include Concomitant and Intensive care medicine.
Between 2017 and 2021, his most popular works were:
- The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients. (145 citations)
- Treatment of a first patient with FLASH-radiotherapy. (94 citations)
- Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species. (94 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Radiation therapy
His scientific interests lie mostly in Internal medicine, Radiation therapy, Oncology, Randomized controlled trial and Myeloid leukemia.
His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
As part of his studies on Radiation therapy, he often connects relevant subjects like Cancer.
His study in Oncology is interdisciplinary in nature, drawing from both Standard of care and Neuroprotection.
His Randomized controlled trial research includes themes of Cetuximab, Head and neck cancer, Carboplatin, Chemoradiotherapy and Subgroup analysis.
His studies deal with areas such as Meta-analysis, Concomitant, Curative surgery and Chemotherapy as well as Head and neck cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
